Brief: Adial Pharmaceuticals Achieves Important Milestone of First Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Azora Therapeutics

05/06/2024 13:36

June 5 (Reuters) - Adial Pharmaceuticals Inc  ADIL.O :
    * ADIAL PHARMACEUTICALS- ACHIEVES IMPORTANT MILESTONE OF
FIRST
PATIENT DOSED IN PHARMACOKINETICS STUDY OF AD04 FOR TREATMENT OF
ALCOHOL USE DISORDER
    * ADIAL PHARMACEUTICALS INC - TOPLINE RESULTS EXPECTED IN
EARLY Q4
2024

Source text for Eikon:  ID:nGNXmgVxH 
Further company coverage:  ADIL.O 

 ((Reuters.Briefs@thomsonreuters.com;))